← Back to CURX

Curanex Pharmaceuticals Inc - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Sep 2025Filed 17/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026Sep 2024Filed 17/11/2025Jun 2024Filed 17/11/2025Mar 2024Filed 17/11/2025
−$3.3−$3.2−$1−$0.1−$0.1−$0.1−$0−$0.1
−$0.12−$0.11−$0.04$0.00−$0.01−$0.04−$0.02
28282624242.42.4

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.